GL1X · GenesisL1 explorer

Research workbench

Crystal structure of a bacterial arylsulfate sulfotransferase catalytic intermediate with 4-methylumbelliferone bound in the active site

Analyse Crystal structure of a bacterial arylsulfate sulfotransferase catalytic… in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

PDB
3ETS
Type
protein
Length
1,127 residues
Chains
2
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Arylsulfate sulfotransferase
EC
2.8.2.22
UniProt
B3HTA9
Ligands
4MU, SO4
Pockets
11 · best druggability 0.71

Structure

x-ray diffraction · 2 distinct chains · 7% helix, 41% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
AArylsulfate sulfotransferase (EC 2.8.2.22)protein5636% helix, 40% strandB3HTA9
BArylsulfate sulfotransferase (EC 2.8.2.22)protein5647% helix, 41% strandB3HTA9

Ligands and binding sites

  • 4MU · 7-hydroxy-4-methyl-2H-chromen-2-one · ligand · 2 copies · chains A, B
  • SO4 · Sulfate ion · ion · 6 copies · chains A, B

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

11 pockets found on a 1 Å grid, 7 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
110470.710.75112empty
24780.650.77474MU
32210.630.8221empty
44530.630.77454MU
52220.620.8120empty

Interfaces

1 interface between chains.

  • A–B · 1796 Ų buried · 34 hydrogen bonds · protein-protein

Modifications

Observed in the structure: 2 disulfide, 2 modified (disulfide, nonstandard).

Compared structures

  • 3ETS · Crystal structure of a bacterial arylsulfate sulfotransferase catalytic intermediate with… · the same entry in another collection · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.